Search Results < Yale Cancer Center

Yale Cancer Center

2514 results

News
Yale Cancer Center Launches Center for Community Engagement and Health Equity
Yale Cancer Center has announced the launch of the Center for Community Engagement and Health Equity (CEHE). Building on the commitment of the Yale Cancer Center to patient-centered cancer care, screening, and prevention across the state of Connecticut, the new center is dedicated to ensuring cancer health equity and improving outcomes, with an emphasis on traditionally underserved neighborhoods.
25 Jan 2020
News
Cancer Deaths Drop
Dr. Roy Herbst talks to Good Morning Connecticut about the drop in cancer deaths.
23 Jan 2020
News
Yale Cancer Center presents Research awards during annual Conclave
Yale Cancer Center (YCC) held its annual Conclave and award ceremony at the New Haven Country Club on Monday, January 13.
22 Jan 2020
News
Yale Cancer Center Awards for Clinical Excellence presented during annual Conclave
Debra Brandt, D.O. and Kevin Kim, M.D. were each honored with the Yale Cancer Center (YCC) Award for Clinical Excellence at YCC’s annual Conclave on Monday, January 13. The night celebrated the accomplishments of goals set for 2019 and honored faculty and staff with clinical and research prizes.
21 Jan 2020
News
Huntington and Parker receive new appointments at Smilow Cancer Hospital
Scott Huntington, M.D., M.P.H., assistant professor of Medicine (Hematology), has been named Medical Director for the Hematology Outpatient Program at Smilow Cancer Hospital and Terri Parker, M.D., assistant Professor of Medicine (Hematology), has been appointed the inaugural Assistant Medical Director for the Smilow Cancer Hospital Care Center in North Haven, which includes multiple myeloma and benign hematology care.
20 Jan 2020
News
Yale Scientists Breach Brain Barriers to Attack Tumors
The brain is a sort of fortress, equipped with barriers designed to keep out dangerous pathogens. But protection comes at a cost: These barriers interfere with the immune system when faced with dire threats such glioblastoma, a deadly brain tumor for which there are few effective treatments.
15 Jan 2020
News
Sanft named Chief Patient Experience Officer at Smilow Cancer Hospital
Tara Sanft, M.D., associate professor of Medicine (Medical Oncology) and Director of the Smilow Cancer Hospital (SCH) Survivorship Clinic, has been appointed the inaugural Chief Patient Experience Officer at Yale Cancer Center (YCC) and SCH at Yale New Haven Hospital.
10 Jan 2020
News
Mougalian appointed Deputy Chief Ambulatory Officer at Smilow Cancer Hospital
Sarah Mougalian, M.D., assistant professor of Medicine (Medical Oncology) has been named the inaugural Deputy Chief Ambulatory Officer at Smilow Cancer Hospital (SCH) at Yale New Haven Hospital.
10 Jan 2020
News
Breast Density Notification Laws not Effective for All Women
A new study suggests that state-mandated notifications on mammogram reports intended to inform women of the health risks related to breast density are not worded effectively.
9 Jan 2020
News
US cancer death rate sees largest-ever single-year drop, report says
Dr. Charles Fuchs comments on a new report by the American Cancer Society showing the rate of people dying from cancer in the United States continued to decline for the 26th year in a row.
8 Jan 2020
News
How to Talk to Your Kids About Your Breast Cancer Diagnosis
Almost three million children and adolescents in the United States have a parent who has or once had cancer, according to the American Academy of Child & Adolescent Psychiatry (AACAP). Among newly diagnosed adults with cancer, one in five has children under 18.
6 Jan 2020
News
Years of excellent care give perspective on the future
Jared Rhodes’ first conversation with Dr. Erik Enquist took place nearly 16 years ago, and he is still a patient. He has since had a prostatectomy and gone through a variety of treatments to help ensure that his cancer does not come back. He’s happy to be alive and also pleased to hear that his local doctor is now also part of a larger and nationally recognized leader in medicine.
1 Jan 2020
News
Fighting Cancer
In the 1960s, doctors in the US developed a radical new approach to treating cancer, using several toxic chemicals at once, and revolutionising survival rates.
30 Dec 2019
News
An Overview of Immunotherapy in Head and Neck Cancer
Barbara Burtness, MD speaks with Aman Shah, MD, about immunotherapy treatments for head and neck cancer.
30 Dec 2019
News
Yale Cancer Center launches Center for Community Engagement and Health Equity
Yale Cancer Center (YCC) announces the launch of the Center for Community Engagement and Health Equity (CEHE). Building on YCC’s longstanding commitment to high-quality, expert, and patient-centered cancer care, screening, and prevention across the state of Connecticut, the new Center is dedicated to ensuring cancer health equity and improving outcomes with an emphasis on traditionally underserved neighborhoods.
23 Dec 2019
News
Brain Scans, Aided by Artificial Intelligence, Reveal as Much About Us as Our DNA, Evan Morris Says.
“Brain scans, aided by artificial intelligence, reveal as much about us as our DNA,” Evan Morris recently wrote in an op-ed in Wired magazine. “Grappling with their ethical implications is vital to scientific integrity.”
20 Dec 2019
News
Yale research leads to new drug to treat bladder, urinary tract cancers
A new drug to treat bladder and urinary tract cancers, developed by Yale Cancer Center and Smilow Cancer Hospital researchers, has been approved by the U.S. Food & Drug Administration.
19 Dec 2019
News
FDA Approves Novel Drug Enfortumab Vedotin for Urothelial Cancer
The US Food and Drug Administration has granted accelerated approval to the novel agent enfortumab vedotin (PADCEV, Astellas) for the treatment of locally advanced or metastatic urothelial cancer that has progressed on chemotherapy and immunotherapy.
19 Dec 2019
News
FDA OKs Antibody-Drug Conjugate for Bladder Cancer
The FDA approved enfortumab vedotin-ejfv (Padcev) on Wednesday for treating patients with locally advanced or metastatic urothelial cancer whose disease has progressed on chemotherapy and immunotherapy.
19 Dec 2019
News
Backed by Yale Cancer Center Research, FDA Approves New Drug for Advanced Bladder Cancer
The U.S. Food and Drug Administration has granted accelerated approval to the drug enfortumab vedotin to treat adult patients with advanced urothelial or bladder cancer. The approval is the direct result of a multi-institutional clinical trial led by Yale Cancer Center and Smilow Cancer Hospital researchers.
18 Dec 2019